How to cite item

Commentary on the clinical trial reported by: Tewari KS, Sill M, Long III HJ, et al. Incorporation of bevacizumab in the treatment of recurrent and metastatic cervical cancer: a phase III randomized trial of the Gynecologic Oncology Group. J Clin Oncol 2013;(suppl; abstr 3)

  
@article{CCO3117,
	author = {Michael L. Friedlander},
	title = {Commentary on the clinical trial reported by: Tewari KS, Sill M, Long III HJ, et al. Incorporation of bevacizumab in the treatment of recurrent and metastatic cervical cancer: a phase III randomized trial of the Gynecologic Oncology Group. J Clin Oncol 2013;(suppl; abstr 3)},
	journal = {Chinese Clinical Oncology},
	volume = {3},
	number = {1},
	year = {2013},
	keywords = {},
	abstract = {One of the highlights of the recent ASCO meeting was the presentation of the results of GOG 240 by Tewari on behalf of his co-investigators in a plenary session (1). This was a positive trial which reported a significant increase in overall survival (OS) of women with metastatic/recurrent cervical cancer who were treated with bevacizumab in combination with chemotherapy. This is likely to change the standard of care of women with recurrent/metastatic cervical cancer in well-resourced regions of the world in particular and deserves review and detailed discussion.},
	issn = {2304-3873},	url = {http://cco.amegroups.com/article/view/3117}
}